Exagen Inc.
XGN
$3.02
-$0.15-4.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.63M | 17.24M | 17.20M | 15.50M | 13.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.63M | 17.24M | 17.20M | 15.50M | 13.66M |
| Cost of Revenue | 7.43M | 7.17M | 6.81M | 6.38M | 5.18M |
| Gross Profit | 9.21M | 10.08M | 10.40M | 9.12M | 8.48M |
| SG&A Expenses | 12.42M | 11.45M | 11.54M | 11.20M | 10.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.61M | 20.34M | 19.83M | 18.86M | 17.04M |
| Operating Income | -4.98M | -3.10M | -2.63M | -3.37M | -3.38M |
| Income Before Tax | -4.66M | -7.09M | -4.40M | -3.75M | -3.75M |
| Income Tax Expenses | 13.00K | 1.00K | 37.00K | -- | 12.00K |
| Earnings from Continuing Operations | -4.67M | -7.09M | -4.44M | -3.75M | -3.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.67M | -7.09M | -4.44M | -3.75M | -3.76M |
| EBIT | -4.98M | -3.10M | -2.63M | -3.37M | -3.38M |
| EBITDA | -4.38M | -2.49M | -2.16M | -2.93M | -2.97M |
| EPS Basic | -0.20 | -0.31 | -0.21 | -0.20 | -0.20 |
| Normalized Basic EPS | -0.17 | -0.12 | -0.11 | -0.13 | -0.13 |
| EPS Diluted | -0.20 | -0.31 | -0.21 | -0.20 | -0.20 |
| Normalized Diluted EPS | -0.17 | -0.12 | -0.11 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 23.58M | 22.94M | 21.09M | 18.56M | 18.43M |
| Average Diluted Shares Outstanding | 23.58M | 22.94M | 21.09M | 18.56M | 18.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |